Research review
Is creatine bad for your liver? What the research does and doesn't show
In healthy people, short-term studies measuring standard liver blood markers alongside creatine haven't found abnormal changes. The more detailed research on creatine and specific liver conditions comes almost entirely from animal studies, which found opposite effects depending on what was causing the liver problem in the first place.
The evidence doesn't support creatine as something that harms a healthy liver at typical doses — the human studies that measured standard liver blood markers found no abnormal change. It also isn't a treatment for an existing liver condition; the more detailed research on that side comes almost entirely from mice, not people, and the animal results point in opposite directions depending on what's causing the liver stress.
What the evidence doesn't support
It doesn't support a claim that creatine damages liver function in healthy people at the doses studied — the human data that exists is reassuring on that specific point, though limited. It also doesn't support creatine as a treatment for anyone who already has a diagnosed liver condition; no human trial has tested creatine in that population at all. What the research does have is animal data on specific liver stresses (a high-fat diet, alcohol), and those two experiments found creatine associated with opposite outcomes.
What the trials found
The most direct human data is a small, older trial: 14 football players took either creatine (15 g/day for a week, then 3 g/day for 7 more weeks) or a placebo, alongside their normal training, while researchers tracked standard blood and urine markers for metabolic, kidney, liver and muscle function. Body mass rose with creatine but not placebo, and creatine kinase activity (a muscle marker) rose too, but the liver and kidney markers tracked showed no significant change from creatine. That's the extent of the controlled human evidence: one small trial, in healthy young athletes, over 8 weeks.
The animal evidence is more detailed and doesn't point in one direction. In one experiment, mice fed a high-fat diet with added creatine had less liver fat buildup and tissue damage than mice on the same diet without creatine. In a separate experiment using the same research group's mice, adding creatine to an alcohol-feeding protocol had the opposite result: more liver fat buildup, more tissue damage, and higher markers of oxidative stress and inflammation than alcohol alone, alongside changes in genes involved in processing alcohol. Put simply: in a diet-driven liver stress model, creatine tracked with less damage; in an alcohol-driven one, it tracked with more.
A 2026 review pulling together this animal and mechanistic research describes creatine as showing a protective association at earlier and more advanced stages of diet-driven fatty liver changes in preclinical models, while flagging the same opposite pattern in alcohol-related liver stress. It calls creatine a candidate worth studying in people with fatty liver changes, explicitly because that clinical trial hasn't been done yet. A separate review of creatine's liver biochemistry describes a proposed mechanism — creatine synthesis normally uses up a liver compound involved in fat handling, so supplementing may reduce that internal demand — alongside a more speculative, less-studied concern that supplementation could raise oxidative stress and generate byproducts with theoretical, unconfirmed cancer-related risk; the review describes the overall adverse-effect literature on creatine as sparse rather than well-mapped.
A review focused specifically on people with an existing liver condition and age-related muscle loss found almost no direct human research to draw on — what support exists comes indirectly, from the animal fatty-liver studies above and from muscle-loss trials in older adults who don't have liver disease. The review frames creatine as a plausible idea for that group worth testing properly, not something with trial evidence behind it yet.
Questions people ask
Is creatine bad for your liver?
The direct human evidence — one small 8-week trial in healthy athletes — found no abnormal change in standard liver blood markers. That's reassuring but limited: it's one trial, in healthy young people, not in anyone with an existing liver condition.
Does creatine affect your kidneys or liver?
For kidneys, a larger, dedicated 19-study review found no known effect on kidney function in people without pre-existing kidney disease — see who should not take creatine for that review. For the liver specifically, the human evidence is much thinner: the one trial that measured liver markers directly found no change, and the more detailed research is limited to mice.
Can creatine cause fatty liver?
No study we found reports that. If anything, the animal research on a high-fat diet found the opposite association — less liver fat buildup with creatine added, not more. That's a mouse study, though, not evidence about what happens in a person's liver.
When to talk to a doctor
If you have a diagnosed liver condition, or bloodwork has flagged an existing liver issue, talk to your doctor before adding creatine — no human trial has tested it in that group, so there's no research-backed guidance to give here either way. Creatine is not a treatment for liver disease, and existing liver test results should always be interpreted by the doctor who ordered them, not by a supplement label.
Related reading: who should not take creatine, creatine side effects, and creatine interactions.
Sources
- Creatine in fatty liver disease: Differential roles, multi-organ lipid regulation, and safety A 2026 review summarizes preclinical (animal and cell) research finding creatine associated with less liver damage in diet-induced fatty liver disease but more in alcohol-related liver disease — evidence that hasn't yet been tested in human patients with either condition.
- Creatine and the Liver: Metabolism and Possible Interactions A review of creatine and liver metabolism describes a proposed mechanism for less fat buildup in the liver, alongside a separate, more speculative concern from a small number of studies about oxidative stress and theoretical carcinogenic byproducts, and says adverse-effect data overall remains sparse.
- Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liver In mice, creatine added to a high-fat diet was linked to less liver fat and damage than the high-fat diet alone, while creatine added to alcohol was linked to more liver fat and damage than alcohol alone — opposite results depending on what was causing the liver stress.
- Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives A review found human research on creatine specifically in chronic liver disease patients is essentially absent — what evidence exists is indirect, drawn from animal fatty-liver studies and from sarcopenia trials in people without liver disease.
- Creatine supplementation does not affect clinical health markers in football players An 8-week trial in football players found no significant change in liver or kidney blood markers with creatine, alongside a normal gain in body mass and a downward trend in uric acid.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.